MACEVICZ STEPHEN 4
4 · ACLARA BIOSCIENCES INC · Filed Dec 1, 2003
Insider Transaction Report
Form 4
MACEVICZ STEPHEN
VP Intellectual Property
Transactions
- Exercise/Conversion
Common Stock
2003-11-26$2.76/sh+10,000$27,600→ 150,000 total - Sale
Common Shares
2003-11-26$3.19/sh−10,000$31,940→ 140,000 total
Footnotes (1)
- [F1]25% of the shares subject to the optioons became exercisable twelve months after the vesting commencement date and 1/48th of the shares subject to the options become exercisable each month thereafter.